LBX Pharmacy Chain JSC
SSE:603883
Balance Sheet
Balance Sheet Decomposition
LBX Pharmacy Chain JSC
Current Assets | 9.1B |
Cash & Short-Term Investments | 938m |
Receivables | 2.8B |
Other Current Assets | 5.4B |
Non-Current Assets | 12.1B |
Long-Term Investments | 436.4m |
PP&E | 4.2B |
Intangibles | 6.6B |
Other Non-Current Assets | 891.2m |
Current Liabilities | 11.2B |
Accounts Payable | 2.2B |
Accrued Liabilities | 596.5m |
Short-Term Debt | 5.6B |
Other Current Liabilities | 2.8B |
Non-Current Liabilities | 3.4B |
Long-Term Debt | 2.7B |
Other Non-Current Liabilities | 625m |
Balance Sheet
LBX Pharmacy Chain JSC
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
467
|
784
|
836
|
1 038
|
756
|
859
|
803
|
680
|
1 396
|
937
|
|
Cash |
7
|
8
|
10
|
8
|
10
|
8
|
7
|
680
|
1 396
|
937
|
|
Cash Equivalents |
460
|
776
|
826
|
1 030
|
746
|
851
|
796
|
0
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
7
|
13
|
26
|
3
|
3
|
2
|
|
Total Receivables |
335
|
453
|
669
|
920
|
1 090
|
1 246
|
1 390
|
1 943
|
2 444
|
2 818
|
|
Accounts Receivables |
313
|
420
|
578
|
799
|
940
|
1 073
|
1 150
|
1 376
|
2 078
|
2 224
|
|
Other Receivables |
22
|
33
|
91
|
121
|
150
|
173
|
240
|
567
|
366
|
595
|
|
Inventory |
739
|
902
|
1 197
|
1 311
|
1 711
|
1 988
|
2 387
|
2 730
|
3 949
|
4 152
|
|
Other Current Assets |
151
|
189
|
241
|
710
|
748
|
970
|
1 030
|
873
|
1 670
|
1 221
|
|
Total Current Assets |
1 692
|
2 328
|
2 941
|
3 979
|
4 311
|
5 076
|
5 635
|
6 228
|
9 463
|
9 130
|
|
PP&E Net |
197
|
212
|
278
|
448
|
1 216
|
997
|
1 092
|
4 687
|
4 191
|
4 191
|
|
PP&E Gross |
197
|
212
|
278
|
448
|
1 216
|
997
|
1 092
|
4 687
|
4 191
|
4 191
|
|
Accumulated Depreciation |
108
|
132
|
160
|
193
|
240
|
295
|
359
|
2 627
|
3 708
|
4 639
|
|
Intangible Assets |
98
|
120
|
181
|
289
|
341
|
435
|
433
|
466
|
600
|
747
|
|
Goodwill |
399
|
760
|
1 221
|
1 521
|
1 987
|
2 324
|
2 809
|
3 695
|
5 493
|
5 836
|
|
Note Receivable |
27
|
29
|
37
|
49
|
56
|
64
|
67
|
63
|
75
|
84
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
68
|
423
|
565
|
981
|
805
|
436
|
|
Other Long-Term Assets |
117
|
350
|
250
|
414
|
505
|
605
|
683
|
837
|
770
|
807
|
|
Other Assets |
399
|
760
|
1 221
|
1 521
|
1 987
|
2 324
|
2 809
|
3 695
|
5 493
|
5 836
|
|
Total Assets |
2 530
N/A
|
3 801
+50%
|
4 910
+29%
|
6 699
+36%
|
8 485
+27%
|
9 924
+17%
|
11 284
+14%
|
16 958
+50%
|
21 397
+26%
|
21 231
-1%
|
|
Liabilities | |||||||||||
Accounts Payable |
487
|
600
|
830
|
879
|
1 097
|
1 286
|
1 534
|
1 769
|
2 367
|
2 209
|
|
Accrued Liabilities |
111
|
127
|
164
|
215
|
231
|
237
|
289
|
336
|
691
|
596
|
|
Short-Term Debt |
610
|
447
|
898
|
1 012
|
2 205
|
3 058
|
3 733
|
4 762
|
5 347
|
5 586
|
|
Current Portion of Long-Term Debt |
2
|
0
|
0
|
11
|
807
|
94
|
16
|
904
|
1 290
|
1 484
|
|
Other Current Liabilities |
153
|
319
|
249
|
534
|
606
|
673
|
719
|
841
|
1 151
|
1 280
|
|
Total Current Liabilities |
1 363
|
1 492
|
2 141
|
2 651
|
4 946
|
5 348
|
6 291
|
8 613
|
10 846
|
11 155
|
|
Long-Term Debt |
58
|
0
|
792
|
888
|
84
|
649
|
118
|
3 500
|
3 400
|
2 750
|
|
Deferred Income Tax |
15
|
14
|
24
|
22
|
35
|
33
|
32
|
44
|
34
|
21
|
|
Minority Interest |
118
|
74
|
95
|
170
|
323
|
388
|
515
|
421
|
568
|
588
|
|
Other Liabilities |
8
|
2
|
8
|
36
|
51
|
20
|
37
|
22
|
19
|
16
|
|
Total Liabilities |
1 562
N/A
|
1 582
+1%
|
3 059
+93%
|
3 768
+23%
|
5 439
+44%
|
6 437
+18%
|
6 994
+9%
|
12 601
+80%
|
14 867
+18%
|
14 530
-2%
|
|
Equity | |||||||||||
Common Stock |
200
|
267
|
267
|
285
|
285
|
287
|
409
|
409
|
585
|
585
|
|
Retained Earnings |
626
|
866
|
1 022
|
1 313
|
1 463
|
1 825
|
2 324
|
2 739
|
3 314
|
3 970
|
|
Additional Paid In Capital |
142
|
1 085
|
561
|
1 333
|
1 298
|
1 372
|
1 587
|
1 139
|
2 637
|
2 174
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
84
|
37
|
15
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
53
|
29
|
14
|
43
|
43
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
57
|
0
|
0
|
0
|
0
|
|
Total Equity |
968
N/A
|
2 218
+129%
|
1 850
-17%
|
2 931
+58%
|
3 046
+4%
|
3 487
+14%
|
4 290
+23%
|
4 358
+2%
|
6 530
+50%
|
6 701
+3%
|
|
Total Liabilities & Equity |
2 530
N/A
|
3 801
+50%
|
4 910
+29%
|
6 699
+36%
|
8 485
+27%
|
9 924
+17%
|
11 284
+14%
|
16 958
+50%
|
21 397
+26%
|
21 231
-1%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
280
|
374
|
374
|
399
|
399
|
401
|
409
|
531
|
582
|
582
|